DEAD

Serial Number

88805781

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Feb 21, 2020

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OPDUALAG NIVOLUMAB/RELATLIMAB) Trademark

Serial Number: 88805781

OPDUALAG NIVOLUMAB/RELATLIMAB) is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on February 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Legal Representation

Attorney of Record

Marilyn F. Kelly

2,565 trademarks filed View all →

Trademark Details

Filing Date

February 21, 2020

Registration Date

Not Registered

Published for Opposition

August 3, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of cancer, all of the foregoing comprising monoclonal antibodies

Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; Providing a website featuring educational information in the field of healthcare and pharmaceutical preparations; all of the foregoing involving monoclonal antibodies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 30, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Oct 30, 2023 ABN6

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 2, 2023 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Aug 2, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Aug 2, 2023 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 9, 2023 EXRA

SOU EXTENSION 3 GRANTED

Mar 7, 2023 EX3G

SOU EXTENSION 3 FILED

Mar 7, 2023 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 7, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2022 EXRA

SOU EXTENSION 2 GRANTED

Sep 13, 2022 EX2G

SOU EXTENSION 2 FILED

Sep 13, 2022 EXT2

SOU TEAS EXTENSION RECEIVED

Sep 13, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 9, 2022 EXRA

SOU EXTENSION 1 GRANTED

Mar 7, 2022 EX1G

SOU EXTENSION 1 FILED

Mar 7, 2022 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 7, 2022 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 28, 2021 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 3, 2021 NPUB

PUBLISHED FOR OPPOSITION

Aug 3, 2021 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 14, 2021 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jun 30, 2021 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 30, 2021 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 23, 2021 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 23, 2021 CRFA

ASSIGNED TO LIE

Jun 22, 2021 ALIE

NOTICE OF REVIVAL - E-MAILED

Apr 9, 2021 NREV

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 8, 2021 TROA

PETITION TO REVIVE-GRANTED

Apr 8, 2021 PETG

TEAS PETITION TO REVIVE RECEIVED

Apr 8, 2021 PROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 22, 2020 GNRN

NON-FINAL ACTION E-MAILED

Sep 22, 2020 GNRT

NON-FINAL ACTION WRITTEN

Sep 22, 2020 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 11, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 11, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 11, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 16, 2020 GNRN

NON-FINAL ACTION E-MAILED

Mar 16, 2020 GNRT

NON-FINAL ACTION WRITTEN

Mar 16, 2020 CNRT

ASSIGNED TO EXAMINER

Mar 16, 2020 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 26, 2020 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 25, 2020 NWOS

NEW APPLICATION ENTERED

Feb 25, 2020 NWAP

Related Trademarks

More from this Owner

EMPLICITI

ZYWISPO

AMWISPO

More in Same Class

CULTIVATE FERTILITY